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Abstract
We have previously shown that racial composition of behavioral intervention groups does not 
affect achieved weight loss. However, it is unclear if the race of the interventionist affects 
intervention outcomes. The objective of this analysis is to estimate the impact of race concordance 
between participant and interventionist on weight change in the initial weight loss phase (phase 1) 
of the Weight Loss Maintenance trial (WLM).
A total of 1,685 overweight or obese adults (body mass index [BMI] 25–45 kg/m2) who were 
taking medication for hypertension and/or dyslipidemia participated in Phase I of the WLM trial. 
All participants received a 6-month intensive behavioral intervention in groups of 15–20 
facilitated by a trained interventionist. The main outcome is change in weight at 6 months.
Participants were on average 55 years of age, 67% female and 44% AA. Three of seventeen 
interventionists were AA, 14 were non-AA. Seventy-three percent of participants shared race 
concordance with the interventionist. There was a small but statistically significant difference in 
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weight change of participants who were the same race as the interventionist (−5.84 kg, SE 0.17) 
compared to those who were not race concordant (−5.04 kg, SE 0.33), a difference of 0.8kg, (p= 
0.04). The impact of concordance on weight change differed by race (i.e., interaction of race and 
concordance was significant, p= 0.02).
In a post-hoc analysis of a group-based behavioral intervention, race concordance for Non-AA 
participants was associated with slightly greater weight loss. Race concordance was not associated 
with weight loss for AA participants.
Introduction
Overweight and obesity have increased in epidemic proportions in the United States. In 
2007–2008 the age adjusted prevalence of overweight/obesity (BMI≥25) was 72.3% in men, 
64.1% in women and 68% overall (1). This trend is alarming as it is well known that 
individuals who are overweight/obese are at increased risk for a wide range of morbidity and 
mortality most notably hypertension (HTN), diabetes mellitus (DM), dyslipidemia, coronary 
heart disease (CHD), cardiovascular disease (CVD) and some types of cancer (2). Racial and 
gender disparities in the prevalence of overweight/obesity are reflected in disparities in the 
prevalence of obesity-related diseases like diabetes and hypertension (3,4). 44% of Non-
Hispanic Blacks are obese in the US as compared to 32% of non-Hispanic whites (1).
Fortunately, modest amounts of weight loss lead to substantial clinical benefits regardless of 
race or sex. For example, 5% weight loss is sufficient to reduce incident hypertension by 
40% (among persons with pre-hypertension) and diabetes by over 50% (among those with 
impaired glucose tolerance) (5,6). Numerous trials indicate that a substantial proportion of 
adults are able to achieve this degree of weight loss with behavioral intervention (5, 6, 7, 8, 
9). There are, however, disparities in the response to weight loss interventions, particularly 
in black women. For example, the Weight Loss Maintenance (WLM) trial (7), which 
enrolled 1685 overweight or obese adults in a group-based 6-month behavioral intervention, 
resulted in an average weight loss of 4.4% among African American (AA) women compared 
to 6.5% in non-AA women. Similar disparities have been seen in other trials (10, 11, 12).
Previous work in physician-patient communication has shown that race concordance 
(defined as a patient and physician sharing the same race) can modify the patient’s 
perception of the encounter and in some instances can affect the patient’s adoption of 
lifestyle recommendations (13, 14, 15, 16). Given the impact of race concordance between 
patient and doctor we considered the possibility that race concordance (or discordance) 
between behavior change interventionists and participants may influence adoption of 
recommendations and thus weight loss outcomes. This paper reports on the association of 
race concordance and weight loss for AA and non-AA participants enrolled in the WLM 
trial.
Methods and Procedures
WLM was an NHLBI-sponsored multicenter study that tested strategies for sustained weight 
loss in a diverse population with CVD risk factors (7). The study included an initial weight 
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loss phase (Phase I) in which 1685 participants all received a 6-month intensive behavioral 
intervention. This analysis focuses on Phase I only. WLM was approved by the Institutional 
Review Board at each participating institution, as well as an NIH-appointed Data and Safety 
Monitoring Board. All participants provided written informed consent. The WLM methods 
and main results have been described in detail elsewhere (7, 17), are available at http://
www.kpchr.org/wlmpublic and are summarized below.
Participants
Participants were recruited from mass mailings, printed advertisements in local newspapers, 
radio advertisements, e-mail broadcasts, and word of mouth. Minority specific recruiting 
efforts included community based-screening events and public service announcements to 
radio stations, and newspapers serving minority populations.
Participants were overweight or obese adults (body mass index [BMI] 25–45 kg/m2) who 
were taking medication for hypertension and/or dyslipidemia. Exclusion criteria included 
medical conditions that precluded full participation in the study; weight loss of greater than 
9kg in the last 3 months; recent use of weight loss medications; history of weight loss 
surgery; and diabetes mellitus.
Weight was measured using a calibrated digital scale with the participant wearing light, 
indoor clothes without shoes. Height was measured at entry using a wall-mounted 
stadiometer. Dietary intake was assessed by the Block Food Frequency Questionnaire (FFQ) 
(18).
Participants wore a triaxial accelerometer (RT3, Stayhealthy, Inc, Monrovia, California) for 
at least four days to estimate total weekly minutes of moderate-to-vigorous physical activity 
(MVPA) (19, 20). Participants also completed questionnaires to assess demographic 
characteristics and medication usage.
The initial weight loss intervention consisted of 20 weekly group sessions conducted over 
approximately 6 months. Intervention goals were 180 minutes per week of moderate-
intensity physical activity, reduced caloric intake, consumption of the Dietary Approaches to 
Stop Hypertension (DASH) dietary pattern (21–24), and weight loss of approximately 1–2 
lbs/week. The intervention was based on behavior change theory (25, 26) and incorporated 
behavior change tools such as setting short-term behavior change goals every week, 
developing specific action plans to accomplish those goals, self-monitoring of dietary intake 
using daily food diaries, self-monitoring of physical activity, social support, problem 
solving, relapse prevention, and motivational interviewing. For more detail regarding the 
weight loss intervention methods used in the first phase of WLM, see the results of Phase I 
published by Hollis et al (7).
Participants were assigned to intervention classes in cohorts of 15–20 individuals, and each 
intervention cohort was led by a single professional interventionist. A total of 17 
interventionists participated in the study, three of whom were AA (one each at the 
Baltimore, Durham, and Baton Rouge sites). Fifteen of the interventionists were registered 
dieticians, one was a health educator and one was a behavioral counselor. All 
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interventionists were experienced in leading behavioral group interventions and received 
centralized as well as local training throughout the study and used standardized program 
content, activities and materials. Additionally, a minority implementation committee 
conducted trial-wide training programs for all staff to highlight the cultural context for both 
AA and Non-AA (7). By design, 14 groups led by an AA interventionist consisted only of 
AA participants.
Race was self identified by participants and interventionists. Interventionists and participants 
were defined as being race concordant if both individuals shared the same race. This 
analysis focuses on the relationship of race concordance with change in weight (as a 
continuous variable) from entry to the end of Phase I in AA and non-AA participants. We 
also assessed the impact of race concordance on the binary outcome of whether participants 
achieved a five percent or greater weight loss.
All participants who entered Phase I are included in this analysis, with missing values 
imputed as noted below. We used one way ANOVA (continuous variables) and Pearson chi-
square tests (categorical variables) to compare Phase I process measures and intermediate 
outcomes (e.g. behavior change) across race concordance groups. We used multiple linear 
regression and multiple logistic regression to compare the impact of race concordance on 
our continuous and dichotomous weight change outcomes, respectively, while adjusting for 
entry level covariates. Two separate classes of models were fit. Model 1 controlled only for 
entry level variables (age, sex, entry weight and site) and assumed the effect of race 
concordance was constant across race and gender subgroups. Model 2 allowed the race 
concordance effect to vary by race and by gender, but still adjusted only for entry level 
variables.
We used multiple imputation procedures (27, 28) to impute missing data, including end of 
Phase I weight for 132 individuals. We then performed separate data analyses on each of the 
imputed datasets and followed Rubin’s rules (27) for combining results across these 
datasets.
Results
Phase I participants averaged 55 years of age; 67% were female and 44% were African 
American. Almost three-quarters of participants were the same race as the interventionist 
(i.e., race-concordant, table 1). Of the discordant cases, most (375 of 454) were AA 
participants in groups led by non-AA interventionists.
Overall, AA participants weighed more at the start of intervention, were more likely to be on 
medications for hypertension and less likely to be on medications for dyslipidemia than 
Non-AA participants. Education and income were similar for AA and Non-AA participants 
(see table 1).
Table 2 shows the key intervention adherence measures for each concordance/discordance 
category. Note that session attendance, number of food diaries kept, and the dietary 
measures were shown to be predictors of weight loss in previous analyses of the phase 1 
weight loss (7). At least 45% of participants in each concordance/discordance category 
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attended at least 17 of 20 group sessions. Additionally, participants in each category kept an 
average of at least 2.4 food records per week, increased consumption of fruit/vegetable by at 
least 3.1 servings per day and decreased their percent calories from fat by at least 6.8 
percent. Non-AA participants who were race concordant with the interventionist completed 
the highest number of food records per week (4.2 ± 2.2) and increased their consumption of 
fruits and vegetables (4.1 ± 3.8) the most as compared to all other groups.
Weight change in Phase I by race was −5.4 kg (4.4) in AA men, −4.1 kg (2.9) in AA 
women, −8.5 kg (12.9) in white men and −5.8 kg (6.1) in white women (7).
We observed a small but statistically significant difference in weight change for participants 
who were the same race as the interventionist (−5.84 kg, SE 0.17) compared to those who 
were not race concordant (−5.04 kg, SE 0.33), a difference of 0.8 kg, p= 0.04. The impact of 
concordance on weight change differed by race (i.e., interaction of race and concordance 
was significant, p= 0.02). Therefore, adjusted linear models were evaluated separately by 
race group (table 3).
After adjusting for age, sex, entry weight, and site, there was a small but statistically 
significant greater weight loss for Non-AA participants with a race-concordant 
interventionist versus those with a race-discordant interventionist (−6.66 ± 0.18kg vs. 
−5.19±.62 kg, p=0.02, 95%CI for the difference = −.20, −2.74). There was not a statistically 
significant difference in weight loss for AA participants with an AA interventionist vs. a 
Non-AA interventionist (−4.58 ± 0.29kg vs. −4.94 ± .28 kg, p=0.37, 95%CI for the 
difference = −.42, −1.14) (see table 3). In a sensitivity analysis where only 2 sites (those 
with all four levels of race concordance) were included in the model the results were similar. 
Non-AA participants with a race-concordant interventionist versus those with a race-
discordant interventionist lost more weight (−6.55 ± 0.29 kg vs. −5.02±.59 kg, p=0.02, 
95%CI for the difference = −.27, −2.78). There was not a statistically significant difference 
in weight loss for AA participants with an AA interventionist vs. a Non-AA interventionist 
(−4.24 ± 0.30kg vs. −4.84 ± .38 kg, p=0.21, 95%CI for the difference = −.35, 1.55).
Discussion
In a cohort of overweight or obese adults there was a small (0.8kg) difference in weight loss 
between participants who were race concordant versus discordant with the interventionist. 
Further, there was a small but statistically significant difference in weight loss for Non-AA 
participants but no difference in weight loss for AA participants. This finding highlights the 
potential importance of race concordance between a Non-AA interventionist and a 
participant. Further, the results in AA suggest that cultural tailoring in WLM may have been 
successful, and could account for the null finding in AA participants.
Concordance in this context can be described as a “similarity or shared identity based on a 
demographic attribute such as race, sex or age” (29). Researchers have looked to race 
concordance, in particular, as a possible explanation for disparities that exist in health care. 
AA and Hispanic patients are more likely to report less continuity in care and perceive 
poorer quality of care and dissatisfaction with their relationship with physicians and the 
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medical system overall (30). There is evidence that in the context of the physician patient 
relationship race concordance is associated with increased health services utilization and 
satisfaction (31) and increased trust in the physician (32).
Unlike the WLM Trial, a study by Cooper and colleagues demonstrated that patients had 
higher satisfaction and perceived their physicians as more participatory when the encounter 
occurred with a physician of the same race (14). Further, Traylor and colleagues showed a 
positive association between race concordance and CVD medication adherence for AA 
patients (16). However, our findings are consistent with studies which demonstrate a lack of 
association of race concordance with management of cardiovascular risk factors (33) and 
weight-related counseling (34). Our null findings in AA may be related to our efforts to 
employ cultural tailoring of all aspects of the trial. These efforts included a minority 
implementation committee that advised the intervention development team, a racially 
diverse team of investigators and study personnel, and “diversity training” for all study 
personnel, including the interventionists. It is very possible that these efforts enhanced 
cultural sensitivity and tailoring, and thereby allowed for similar weight loss outcomes 
regardless of race concordance between interventionists and AA participants. Additionally, 
the experience of many AA includes frequently interacting with non-AAs in different 
settings. It may be that participants in this trial had a higher level of comfort in 
heterogeneous group settings. Lastly, the group dynamic could have created an atmosphere 
of familiarity that helped both participants and interventionists overcome barriers in 
communication that may have existed secondary to race.
Non-AA in this analysis who were in a group with a Non-AA interventionist lost slightly but 
significantly more weight than Non-AA participants who were in a group with an AA 
interventionist. One might assume that Non-AA who were race discordant with the 
interventionist were not as successful in their weight loss secondary to race discordance 
alone. In reality, there are many potential factors like personal beliefs and values and 
communication style that play a role in establishing a good working relationship with 
another individual. And, for each individual, the importance of the individual factors is 
different. Indeed, Street et al (29) discuss the importance of taking into account multiple 
factors of both members of a dyad as well as the contextual factors that play a role in an 
interaction.
A study by Schnitter and Liang suggests that in some cases patients who prefer racial 
concordance with their physician perform better when concordance exists (15). That is, the 
effect of concordance on behavior change was only important when a patient expressed a 
preference for a physician who was concordant. In this case, a pre-determined preference by 
the patient drove the perception of the relationship and the health outcomes that resulted 
were directly affected by racial concordance of the patient and physician. Perhaps patient 
preference is driving the association of race concordance and weight loss, albeit small, in the 
Non-AA participants.
Group dynamics may have influenced the results in the 79 Non-AA participants who were 
discordant with the interventionist. The conduct of the behavioral intervention groups in 
WLM (and other studies) involves a great deal of peer-mentoring and social support. The 
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interventionist facilitates the groups, but is trained to avoid didactic or overly directive 
behavior. The relationships among participants in a group may contribute to their success 
with weight loss, and in fact may be more important than their interactions with the 
interventionist. Indeed, the engagement and success of a “partner” in weight loss efforts is 
associated with success of the index individual (35). The group setting in WLM phase I may 
have simulated this type of partnership. Indeed, it may be important that many of the AA 
participants (271 of 678) were in all-AA groups. Although there was no significant effect of 
all-AA verses mixed race groups on weight loss outcomes (36), the combination of an all-
AA group with an AA interventionist may have enhanced weight loss in AA. Unfortunately, 
we have inadequate sample size to test for this 3-way interaction.
It is possible that the difference in weight loss for Non-AA participants who were race 
concordant versus discordant with the interventionist may be related to the level of comfort 
AA interventionists had in interacting with Non-AA participants. The traditional focus of 
diversity training and cultural tailoring has been from the perspective of training study 
personnel to be able to relate to the AA participant’s cultural perspective. Perhaps cultural 
tailoring and diversity training should address any potential lack of familiarity or differences 
that exist between the interventionist and participants of a different race.
Lastly, the number of Non-AA who had an AA interventionist was small (n=79). Three of 
the WLM clinical centers (Baltimore, Baton Rouge and Durham) participated in an ancillary 
study in which some of the weight loss groups were structured to include only AA 
participants to evaluate the impact of racial mix on weight loss results in the AA 
participants. The 3 AA interventionists in the trial were principally assigned to lead the all 
AA groups leaving them limited capacity to run the mixed groups. Hence, the small number 
of non-AA participants assigned to groups with an AA interventionist. With so few 
participants in this category it is difficult to separate personalities and other important 
characteristics, from potential race concordance effects.
The strengths of this study are the size and diversity of the cohort as well as the 
interventionists. Also, the analysis is unique in that to our knowledge this is the only 
manuscript to date that has looked at the impact of participant and interventionist race 
concordance. The fact that the interventions were developed for cultural appropriateness for 
AA allows us to assess this impact in a perhaps optimal setting.
The limitations of the study include the fact that the cohort of individuals was relatively well 
educated, potentially limiting generalizability. However, this fact also eliminates 
socioeconomic factors as confounders for race. In addition, this analysis demonstrates 
association but cannot determine cause and effect. As noted above, group dynamics that 
varied considerably between groups may have influenced the results leading to coincidental 
association with interventionist race. Lastly, we cannot isolate particular elements of the 
WLM intervention or the training of the interventionists that prevented differences in weight 
loss by concordance/discordance between AA participants and interventionists or led to such 
differences in non-AA participants. Ideally, future research will determine what aspects of 
cultural tailoring were most effective for AA and what aspects may be needed for non-AA.
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The results of this study demonstrate that although there was a small difference in weight 
loss in participants who were race concordant versus discordant with the interventionist, the 
difference was not a critical factor in determining successful weight loss as participants in 
Phase I had a mean (SD) weight loss of 5.8kg (4.4). However, the interaction of race and 
concordance demonstrated that, to the extent that concordance mattered, race concordance 
was associated with more weight loss in Non-AA than AA participants.
Acknowledgments
The Weight Loss Maintenance trial was sponsored by National Heart, Lung, Blood Institute grants 5-U01 
HL68734, 5-U01 HL68676, 5-U01 HL68790, 5-U01 HL68920, and 5-HL68955.
References
1. Flegal K, Carroll MD, Ogden CL, Curtin LR. Prevalence and Trends in Obesity Among US Adults, 
1999–2008. JAMA. 2010; 303:235–241. [PubMed: 20071471] 
2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and 
Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 
1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the 
Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 
2006; 113:898–918. [PubMed: 16380542] 
3. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and 
national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health 
and Human Services, Centers for Disease Control and Prevention; 2008. 
4. Lloyd-Jones D, Adams R, Brown TM, et al. Heart Disease and Stroke Statistics—2010 Update. A 
Report from the American Heart Association. Circulation. 2010; 121:e1–e170. [PubMed: 
20048228] 
5. Knowler WC, Barrett-Conner E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, et 
al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J 
Med. 2002; 346:393–403. [PubMed: 11832527] 
6. Stevens VJ, Corrigan SA, Obarzanek E, et al. Weight loss intervention in phase 1 of the trials of 
hypertension prevention. The TOHP Collaborative Research Group. Arch Intern Med. 1993; 
153:849–858. [PubMed: 8466377] 
7. Hollis JF, Gullion CM, Stevens VJ, et al. for the Weight Loss Maintenance Trial Research Group. 
Weight loss during the initial intensive intervention phase of the Weight Loss Maintenance Trial. 
American Journal of Preventive Medicine. 2008; 35:118–126. [PubMed: 18617080] 
8. Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on 
blood pressure control: Main results of the PREMIER clinical trial. JAMA. 2003; 289:2083–2093. 
[PubMed: 12709466] 
9. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of 
hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in 
the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998; 279:839–46. [PubMed: 
9515998] 
10. Kumanyika SK, Obarzanek E, Stevens VJ, Hebert PR, Whelton PK. Weight loss experience of 
black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr. 1991; 53:1631S–
1638S. [PubMed: 2031498] 
11. Wing RR, Anglin K. Effectiveness of a behavioral weight control program for blacks and whites 
with NIDDM. Diabetes Care. 1996; 19:409–413. [PubMed: 8732700] 
12. Kumanyika SK, Espeland MA, Bahnson JL, et al. Ethnic comparison of weight loss in the trial of 
non-pharmacologic interventions in the elderly. Obesity Res. 2002; 10:96–106.
13. Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, Ford DE. Race, Gender and 
Partnership in the patient-physician relationship. JAMA. 1999; 282:583–589. [PubMed: 
10450723] 
Batch et al. Page 8













14. Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered 
communication, ratings of care, and concordance of patient physician race. Annals Int Med. 2003; 
139:907–916.
15. Schnittker J, Liang K. The promise and limits of racial/ethnic concordance in physician-patient 
interaction. J of Health Politics, Policy and Law. 2006; 31:811–838.
16. Traylor AH, Schmittdiel JA, Uratsu BA, Mangione CM, Subramanian U. Adherence to 
cardiovascular disease medications: Does patient-provider race/ethnicity and language 
concordance matter? JGIM. 2010; 25:1172–7. [PubMed: 20571929] 
17. Brantley P, Appel L, Hollis J, et al. Design considerations and rationale of a multi-center trial to 
sustain weight loss: the Weight Loss Maintenance Trial. Clin Trials. 2008; 5:546–56. [PubMed: 
18827047] 
18. Block G, Subar AF. Estimates of nutrient intake from a food frequency questionnaire: the 1987 
National Health Interview Survey. J Am Diet Assoc. 1992; 92:969–77. [PubMed: 1640041] 
19. Chen C, Jerome GJ, Laferriere D, Young D, Vollmer WM. Procedures used to standardize data 
collected by RT3 triaxial accelerometers in a large scale weight-loss trial. J Phys Act Health. 2009; 
6:354–359. [PubMed: 19564665] 
20. Jerome GJ, Young DR, Laferriere D, Chen C, Vollmer WM. Reliability of RT3 accelerometers 
among overweight and obese adults. Med Sci Sports Exerc. 2009; 41:110–4. [PubMed: 19092700] 
21. Appel LJ, Moore TJ, Obarzanek E, et al. for the DASH Collaborative Research Group. A clinical 
trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997; 336:1117–24. 
[PubMed: 9099655] 
22. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium 
and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative 
Research Group. N Engl J Med. 2001; 344:3–10. [PubMed: 11136953] 
23. Harsha DW, Sacks FM, Obarzanek E, et al. Effect of dietary sodium intake on blood lipids: results 
from the DASH-sodium trial. Hypertension. 2004; 43:393–8. [PubMed: 14707154] 
24. Appel LJ, Sacks FM, Carey VJ, et al. Effects of protein, monounsaturated fat, and carbohydrate 
intake on blood pressure and serum lipids: results of the Omni Heart randomized trial. JAMA. 
2005; 294:2455–64. [PubMed: 16287956] 
25. Bandura, A. Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, 
NJ: Prentice Hal; 1986. 
26. Prochaska JM, Prochaska JO, Levesque DA. A transtheoretical approach to changing 
organizations. Adm Policy Ment Health. 2001; 28:247–61. [PubMed: 11577653] 
27. Little, RJA.; Rubin, DB. Statistical Analysis with Missing Data. 2. Wiley; Hoboken, NJ: 2002. 
28. Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern 
missing data procedures. Psychol Methods. 2001; 6:330–351. [PubMed: 11778676] 
29. Street RL, O’Malley KJ, Cooper LA, Haidet P. Understanding concordance in patient-physician 
relationships: Personal and ethnic dimensions of shared identity. Annals of Family Medicine. 
2008; 6:198–205. [PubMed: 18474881] 
30. Institute of Medicine. Unequal Treatment: Confronting racial and ethnic disparities in health care. 
Washington, DC: National Academy Press; 2002. 
31. LaVeist, Ta; Nuru-Jeter, A.; Jones, KE. The association of doctor-patient race concordance with 
health services utilization. J Public Health Policy. 2003; 24:312–323. [PubMed: 15015865] 
32. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Power NR. Race and trust in the health care 
system. Public Health Rep. 2003; 7:358–365. [PubMed: 12815085] 
33. Traylor AH, Subramanian U, Uratsu CS, Mangione CM, Selby JV, Schmittdiel JA. Patient race/
ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular 
disease risk factors for patients with diabetes. Diabetes Care. 2010; 33:520–525. [PubMed: 
20009094] 
34. Bleich SN, Simon AE, Cooper LA. Impact of patient-doctor race concordance on rates of weight 
related counseling in visits by black and white obese individuals. Obesity. 2012; 20(3):562–70. 
[PubMed: 21233803] 
35. Kumanyika SK, Wadden TA, Shults J, et al. Trial of family and friend support for weight loss in 
African American adults. Arch Int Med. 2009; 169:1795–1804. [PubMed: 19858438] 
Batch et al. Page 9













36. Ard JD, Kumanyika S, Stevens VJ, et al. Effect of group racial composition on weight loss in 
African Americans. Obesity. 2008; 16:306–310. [PubMed: 18239637] 
Batch et al. Page 10

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Obesity (Silver Spring). Author manuscript; available in PMC 2013 November 21.
